Nelson Cabatuan - Net Worth and Insider Trading
Nelson Cabatuan Net Worth
The estimated net worth of Nelson Cabatuan is at least $116 dollars as of 2025-05-04. Nelson Cabatuan is the Principal Accounting Officer of Rigel Pharmaceuticals Inc and owns about 6 shares of Rigel Pharmaceuticals Inc (RIGL) stock worth over $116. Details can be seen in Nelson Cabatuan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nelson Cabatuan has not made any transactions after 2018-10-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nelson Cabatuan
Nelson Cabatuan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nelson Cabatuan owns 2 companies in total, including Rigel Pharmaceuticals Inc (RIGL) , and Rain Oncology Inc (RAIN) .
Click here to see the complete history of Nelson Cabatuan’s form 4 insider trades.
Insider Ownership Summary of Nelson Cabatuan
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| RIGL | Rigel Pharmaceuticals Inc | 2018-10-12 | Principal Accounting Officer |
| RAIN | Rain Oncology Inc | 2021-04-22 | See Remarks |
Nelson Cabatuan Latest Holdings Summary
Nelson Cabatuan currently owns a total of 1 stock. Nelson Cabatuan owns 6 shares of Rigel Pharmaceuticals Inc (RIGL) as of October 12, 2018, with a value of $116.
Latest Holdings of Nelson Cabatuan
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RIGL | Rigel Pharmaceuticals Inc | 2018-10-12 | 6 | 19.36 | 116 |
Holding Weightings of Nelson Cabatuan
Nelson Cabatuan Form 4 Trading Tracker
According to the SEC Form 4 filings, Nelson Cabatuan has made a total of 0 transactions in Rigel Pharmaceuticals Inc (RIGL) over the past 5 years. The most-recent trade in Rigel Pharmaceuticals Inc is the sale of 1,000 shares on October 12, 2018, which brought Nelson Cabatuan around $31,200.
Insider Trading History of Nelson Cabatuan
- 1
Nelson Cabatuan Trading Performance
Nelson Cabatuan Ownership Network
Ownership Network List of Nelson Cabatuan
Ownership Network Relation of Nelson Cabatuan
Nelson Cabatuan Owned Company Details
What does Rigel Pharmaceuticals Inc do?
Who are the key executives at Rigel Pharmaceuticals Inc?
Nelson Cabatuan is the Principal Accounting Officer of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & GC & Corp Sec Raymond J. Furey , EVP & Chief Financial Officer Dean L Schorno , and EVP & Chief Commercial Officer David A Santos .
Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary
Over the past 18 months, Nelson Cabatuan made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 62,246 shares made by Raul R Rodriguez , a net sale of 18,440 shares made by David A Santos , and a net sale of 16,398 shares made by Dean L Schorno .
In summary, during the past 3 months, insiders sold 19,830 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 19,830 shares. During the past 18 months, 27,834 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 27,834 shares.
Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rigel Pharmaceuticals Inc Insider Transactions
Nelson Cabatuan Mailing Address
Above is the net worth, insider trading, and ownership report for Nelson Cabatuan. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Nelson Cabatuan's mailing address is: South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
